Biodexa Pharmaceuticals Plc (BDRX)
1.12
-0.06
(-5.08%)
USD |
NASDAQ |
Feb 24, 16:00
1.12
0.00 (0.00%)
Pre-Market: 08:41
Biodexa Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NuCana Plc | 2.928M |
| Autolus Therapeutics Plc | 27.72M |
| Mereo BioPharma Group Plc | 4.243M |
| Bicycle Therapeutics Plc | 65.63M |
| DBV Technologies SA | 26.82M |